Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1993 1
1999 1
2000 1
2002 8
2003 5
2004 5
2005 2
2006 7
2007 10
2008 20
2009 26
2010 37
2011 46
2012 47
2013 56
2014 87
2015 98
2016 105
2017 106
2018 135
2019 158
2020 204
2021 234
2022 286
2023 268
2024 158

Text availability

Article attribute

Article type

Publication date

Search Results

1,879 results

Results by year

Filters applied: . Clear all
Page 1
Sepsis induces non-classic innate immune memory in granulocytes.
Wang B, Zhu L, Jia B, Zhao C, Zhang J, Li F, Li J, Ding N, Zhang C, Hao Y, Tong S, Wang J, Li G, Fan Y, Zhang H, Li R, Du J, Kong Y, Zhang Y, Yang X, Han J, Yu Z, Du Z, Zheng H, Kosan C, Li A, Chen C, Ma Y, Zeng H. Wang B, et al. Among authors: ding n. Cell Rep. 2023 Sep 26;42(9):113044. doi: 10.1016/j.celrep.2023.113044. Epub 2023 Aug 28. Cell Rep. 2023. PMID: 37643085 Free article.
Response.
Sheng T, Wang S, Ji J, Ding N, Luo G, Chen C. Sheng T, et al. Among authors: ding n. Gastrointest Endosc. 2024 Jun;99(6):1075. doi: 10.1016/j.gie.2024.02.006. Gastrointest Endosc. 2024. PMID: 38762303 No abstract available.
Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis.
Jin P, Jiang J, Zhou L, Huang Z, Qin S, Chen HN, Peng L, Zhang Z, Li B, Luo M, Zhang T, Ming H, Ding N, Li L, Xie N, Gao W, Zhang W, Nice EC, Wei Y, Huang C. Jin P, et al. Among authors: ding n. EMBO Mol Med. 2022 Dec 7;14(12):e16082. doi: 10.15252/emmm.202216082. Epub 2022 Nov 2. EMBO Mol Med. 2022. PMID: 36321555 Free PMC article.
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis.
Xi Y, LaCanna R, Ma HY, N'Diaye EN, Gierke S, Caplazi P, Sagolla M, Huang Z, Lucio L, Arlantico A, Jeet S, Brightbill H, Emson C, Wong A, Morshead KB, DePianto DJ, Roose-Girma M, Yu C, Tam L, Jia G, Ramalingam TR, Marsters S, Ashkenazi A, Kim SH, Kelly R, Wu S, Wolters PJ, Feldstein AE, Vander Heiden JA, Ding N. Xi Y, et al. Among authors: ding n. Cell Metab. 2022 Sep 6;34(9):1377-1393.e8. doi: 10.1016/j.cmet.2022.07.009. Epub 2022 Aug 19. Cell Metab. 2022. PMID: 35987202 Free article.
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D'Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel JF, Hertervig E; GETAID and the SPARE-Biocycle research group. Louis E, et al. Among authors: ding n. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):215-227. doi: 10.1016/S2468-1253(22)00385-5. Epub 2023 Jan 11. Lancet Gastroenterol Hepatol. 2023. PMID: 36640794 Free PMC article. Clinical Trial.
1,879 results